Publisher Correction: IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | Zhen Li, Zewei Wang, Yang Liu, Lei Yang, Ling Gu, Hailong Li, Wei Wang |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Online Access: | https://doi.org/10.1038/s41598-025-98177-8 |
Similar Items
IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment
by: Zhen Li, et al.
Published: (2025-02-01)
by: Zhen Li, et al.
Published: (2025-02-01)
Intravesical chemotherapy in BCG waiting period may prolong time to recurrence for high-risk NMIBC patients
by: Zhen Li, et al.
Published: (2025-02-01)
by: Zhen Li, et al.
Published: (2025-02-01)
The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.
by: Shenghua Liu, et al.
Published: (2015-01-01)
by: Shenghua Liu, et al.
Published: (2015-01-01)
Integrating urinary dual-gene methylation and VI-RADS score to predict residual tumors after TURBT in NMIBC: a nomogram-based model
by: Wang Qi, et al.
Published: (2025-10-01)
by: Wang Qi, et al.
Published: (2025-10-01)
Does the Decrease in Neutrophil-lymphocyte Ratio after BCG Treatment Be a Prognostic Marker for NMIBC?
by: Aykut Başer
Published: (2020-12-01)
by: Aykut Başer
Published: (2020-12-01)
BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies
by: Georgia Bourlotos, et al.
Published: (2024-01-01)
by: Georgia Bourlotos, et al.
Published: (2024-01-01)
Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study
by: Jimpei Miyakawa, et al.
Published: (2024-08-01)
by: Jimpei Miyakawa, et al.
Published: (2024-08-01)
Intravesical BCG: Possible Protective Impact Against COVID-19 in NMIBC Patients
by: Gabriel GLUCK, et al.
Published: (2020-06-01)
by: Gabriel GLUCK, et al.
Published: (2020-06-01)
Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders
by: Toni Boban, et al.
Published: (2025-03-01)
by: Toni Boban, et al.
Published: (2025-03-01)
The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
by: Qi-Dong Xia, et al.
Published: (2024-10-01)
by: Qi-Dong Xia, et al.
Published: (2024-10-01)
On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC
by: Bernadett E. Szabados, et al.
Published: (2025-04-01)
by: Bernadett E. Szabados, et al.
Published: (2025-04-01)
Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting
by: Luis Martínez-Piñeiro
Published: (2023-02-01)
by: Luis Martínez-Piñeiro
Published: (2023-02-01)
Continued Use and Expansion of Photodynamic TURBT
by: Michael E. Rezaee, et al.
Published: (2023-05-01)
by: Michael E. Rezaee, et al.
Published: (2023-05-01)
Surgical treatment of the inferior vena cava (IVC) leiomyosarcoma
by: V. І. Rusin, et al.
Published: (2021-11-01)
by: V. І. Rusin, et al.
Published: (2021-11-01)
P17 Estonian TURBT results in RESECT Study
by: R. Okas, et al.
Published: (2024-05-01)
by: R. Okas, et al.
Published: (2024-05-01)
Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC): Current Guidance and Experience from Clinical Practice
by: Naselli A, et al.
Published: (2024-11-01)
by: Naselli A, et al.
Published: (2024-11-01)
Comparison of dosimetry between TOMO and VMAT after TURBT for bladder cancer
by: LI Hong-ming, YU Lang, LI Rui, SHEN Jie, ZHANG Fu-quan, WU Song
Published: (2020-11-01)
by: LI Hong-ming, YU Lang, LI Rui, SHEN Jie, ZHANG Fu-quan, WU Song
Published: (2020-11-01)
“What IVC?”: Deep Vein Thrombosis in the Context of IVC Dysgenesis
by: Thomas C. Varkey, et al.
Published: (2023-05-01)
by: Thomas C. Varkey, et al.
Published: (2023-05-01)
Endovascular management of IVC syndrome after IVC filter placement
by: Konstantinos Marmagkiolis, et al.
Published: (2015-09-01)
by: Konstantinos Marmagkiolis, et al.
Published: (2015-09-01)
Is a second TUR necessary in patients with primary high‐grade Ta NMIBC, particularly in the context of initial cases?
by: Satoki Abe, et al.
Published: (2025-09-01)
by: Satoki Abe, et al.
Published: (2025-09-01)
Explore the prognostic influence of the treatment sequence of TURBT-chemotherapy combination for patients with localized muscle-invasive bladder cancer
by: Yu Xia, et al.
Published: (2024-04-01)
by: Yu Xia, et al.
Published: (2024-04-01)
A preliminary report: The application of HO-YAG laser in turbt with enbloc method
by: Chi-Wen Lo, et al.
Published: (2016-06-01)
by: Chi-Wen Lo, et al.
Published: (2016-06-01)
426 A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
by: Neal Shore, et al.
Published: (2021-11-01)
by: Neal Shore, et al.
Published: (2021-11-01)
The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
by: Jian-Xuan Sun, et al.
Published: (2023-06-01)
by: Jian-Xuan Sun, et al.
Published: (2023-06-01)
A rare complication of intravesical early instillation of mitomycin C after TURBT
by: Humam Hatem, et al.
Published: (2019-09-01)
by: Humam Hatem, et al.
Published: (2019-09-01)
RARN and IVC tumor thrombectomy
by: Haitao Dai, et al.
Published: (2025-03-01)
by: Haitao Dai, et al.
Published: (2025-03-01)
Resection of Primary Renal Leiomyosarcoma Involving the Inferior Vena Cava (IVC) with IVC Resection and Reconstruction
by: Khaled Alshawwa, et al.
Published: (2022-01-01)
by: Khaled Alshawwa, et al.
Published: (2022-01-01)
Exceedingly rare incidence of a double inferior vena cava (IVC) with azygos continuation of left IVC
by: Adeleh Dadkhah, et al.
Published: (2024-06-01)
by: Adeleh Dadkhah, et al.
Published: (2024-06-01)
BCG and praziquantel for schistosomiasis treatment
by: Luciana de Gouvêa Viana, et al.
Published: (1996-10-01)
by: Luciana de Gouvêa Viana, et al.
Published: (1996-10-01)
Superficial Bladder Cancer Recurrence on First Check Cystoscopy after Transurethral Resection (TURBT).
by: Insar Hussain Malik
Published: (2016-06-01)
by: Insar Hussain Malik
Published: (2016-06-01)
Positional priapism and scrotal swelling: An unusual presentation of IVC filter associated thrombosis and May-Thurner syndrome
by: Shiv Dalla, MD, MS, et al.
Published: (2024-09-01)
by: Shiv Dalla, MD, MS, et al.
Published: (2024-09-01)
Renal Metastasis of Osteosarcoma with IVC Thrombus
by: Prem Raj Sigdel, et al.
Published: (2021-01-01)
by: Prem Raj Sigdel, et al.
Published: (2021-01-01)
Budd-Chiari Syndrome Treated With IVC Stenting With Subsequent Right Hepatic Vein to IVC Retrograde Sharp Recanalization
by: Andrew C. Gordon, et al.
Published: (2025-01-01)
by: Andrew C. Gordon, et al.
Published: (2025-01-01)
Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
by: Young Joon Moon, et al.
Published: (2022-01-01)
by: Young Joon Moon, et al.
Published: (2022-01-01)
Holmium Laser Enucleation (HoLEP) as a strategy to reduce NMIBC recurrence and progression
by: L. Di Gianfrancesco, et al.
Published: (2025-09-01)
by: L. Di Gianfrancesco, et al.
Published: (2025-09-01)
P16 Outpatient laser ablation of recurrent NMIBC, a prospective feasibility study
by: V. Kumarasegaram, et al.
Published: (2024-05-01)
by: V. Kumarasegaram, et al.
Published: (2024-05-01)
Continuous spinal anesthesia in a case of Eisenmenger syndrome undergoing TURBT- A case report
by: Hassan M. Ahmed
Published: (2025-10-01)
by: Hassan M. Ahmed
Published: (2025-10-01)
Double-J stenting during TURBT increases risk of metachronous upper tract urothelial carcinoma
by: Zhengfeng Wu, et al.
Published: (2025-06-01)
by: Zhengfeng Wu, et al.
Published: (2025-06-01)
ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol
by: Max Kates, et al.
Published: (2024-06-01)
by: Max Kates, et al.
Published: (2024-06-01)
Role of Inferior Vena Cava (IVC) Recanalization in Patients with Back Pain, Secondary to IVC Obstruction in Budd–Chiari Syndrome
by: Vijay Kubihal, et al.
Published: (2023-01-01)
by: Vijay Kubihal, et al.
Published: (2023-01-01)
Similar Items
-
IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment
by: Zhen Li, et al.
Published: (2025-02-01) -
Intravesical chemotherapy in BCG waiting period may prolong time to recurrence for high-risk NMIBC patients
by: Zhen Li, et al.
Published: (2025-02-01) -
The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.
by: Shenghua Liu, et al.
Published: (2015-01-01) -
Integrating urinary dual-gene methylation and VI-RADS score to predict residual tumors after TURBT in NMIBC: a nomogram-based model
by: Wang Qi, et al.
Published: (2025-10-01) -
Does the Decrease in Neutrophil-lymphocyte Ratio after BCG Treatment Be a Prognostic Marker for NMIBC?
by: Aykut Başer
Published: (2020-12-01)
